Author

Gong Li

Nanjing Drum Tower HospitalORCID 0000-0002-2817-0162Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Chao QiniD· 1 shared Chen Gao· 1 shared Cheng Zhang· 1 shared Dan ZhangiD· 1 shared Fei Zhao· 1 shared Jiayi Qian· 1 shared Jing YaoiD· 1 shared Jixian WangiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chao QinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 1, 2026

Dissecting the TMEM132A-EGFR Dependency to Unlock Translational Therapeutic Opportunities for Pan-Solid Tumor

Yaru Fu, Qiqi Ni, Junhao Wang…·Xijuan Liu

This paper identifies TMEM132A as a pan-cancer target that stabilizes EGFR and drives lipid synthesis, and develops a nanobody to inhibit this interaction, showing antitumor activity in resistant models.

DOI 10.64898/2026.08.30.746586

humanproteomics

𝕏 PostBluesky

GeneticsbioRxivPreprintAug 12, 2026

A gene-augmentation framework for selected early-stage autosomal recessive retinitis pigmentosa genotypes

Peimin Ma, X G Sun, Shuya Xu…·Yunlu Xue

The paper identifies tractable genes for gene-augmentation therapy in autosomal recessive retinitis pigmentosa using AAV vectors and evaluates PDE6B in animal models.

DOI 10.64898/2026.07.25.740701

mouserat

𝕏 PostBluesky